Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PGEN | RCUS |
|---|---|---|
| Price | $7.74 | $24.74 |
| Change today | ▼ 9.37% | ▲ 1.23% |
| Market cap | $2.77B | $3.15B |
| Return, 3 months | +40.5% | -18.2% |
| Return, year to date | +85.2% | +3.8% |
| Return, 1 year | +146.5% | +70.9% |
| P/E (TTM) | -7.2 | -6.3 |
| P/B | 63.4 | 6.8 |
| P/E percentile vs own 5y | 8th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +93.8% | +70.3% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 53 | 39 |
| 30-day volatility | 56.1% | 47.3% |
| Max drawdown, 1 year | -40.5% | -27.8% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
